What is piptaz given for
Piptaz (piperacillin-tazobactam) is a broad-spectrum antibiotic combination used to treat serious bacterial infections. Piperacillin is a penicillin-type antibiotic, and tazobactam is a beta-lactamase inhibitor that protects piperacillin from being broken down by resistant bacteria.
Searching sources...
Reading File
Searching the Web
piperacillin tazobactam piptaz indications uses
Finding Sources
Reading File
Reading File
Here is a complete overview of what Piptaz (piperacillin-tazobactam) is given for:
Piptaz (Piperacillin-Tazobactam) - What It's Used For
What it is: Piptaz is a combination antibiotic - piperacillin (an extended-spectrum penicillin) plus tazobactam (a beta-lactamase inhibitor). The tazobactam protects piperacillin from being broken down by bacterial enzymes, greatly widening the range of bacteria it can kill.
Approved Indications
| Infection Type | Details |
|---|---|
| Intra-abdominal infections | Appendicitis (with rupture/abscess), peritonitis - particularly against E. coli and Bacteroides fragilis group |
| Nosocomial (hospital-acquired) pneumonia | Moderate to severe; covers Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, Acinetobacter baumannii, Haemophilus influenzae - usually combined with an aminoglycoside for Pseudomonas |
| Skin and soft tissue infections | Cellulitis, cutaneous abscesses, diabetic foot infections, ischemic foot infections caused by beta-lactamase-producing S. aureus |
| Female pelvic infections | Post-partum endometritis, pelvic inflammatory disease |
| Community-acquired pneumonia | Moderate severity only, due to beta-lactamase-producing H. influenzae |
| Urinary tract infections | Complicated UTIs |
Common Off-Label / Clinical Uses
- Febrile neutropenia - frequently used empirically in immunocompromised patients (often with amikacin)
- Sepsis / septic shock - broad empirical cover while awaiting cultures
- Cystic fibrosis - antipseudomonal dosing (350-600 mg/kg/day divided every 4-6 hours)
- Complicated wound infections
Key Bacteria It Covers
Piptaz has broad gram-positive, gram-negative, and anaerobic coverage, including:
- Pseudomonas aeruginosa (important - many other penicillins can't cover this)
- Staphylococcus aureus (methicillin-sensitive strains)
- Enterococcus faecalis
- E. coli, Klebsiella, Proteus, Enterobacter
- Bacteroides fragilis (anaerobe)
- Haemophilus influenzae
It does not cover MRSA or extended-spectrum beta-lactamase (ESBL)-producing organisms reliably.
How It's Given
- Given by IV infusion only (not oral)
- Standard adult dosing: 3.375 g every 6 hours for most infections; 4.5 g every 6 hours for nosocomial pneumonia
- Extended infusion over 4 hours is often used to optimize bacterial killing (especially against organisms with higher MICs)
- Dose adjustment needed in renal impairment
Important Cautions
- Increased risk of acute kidney injury when combined with IV vancomycin (a common pairing to be aware of)
- Can cause abnormal platelet function and bleeding
- Rare but serious skin reactions (Stevens-Johnson syndrome, DRESS, TEN)
- Can falsely lower aminoglycoside blood levels if infused close together - allow at least 2 hours between infusions
Sources: The Harriet Lane Handbook (Johns Hopkins), 23rd ed., p. 1303-1304; FDA Prescribing Information; Medscape Drug Reference
This is a shared conversation. Sign in to Orris to start your own chat.